Jafron Biomedical Co.,Ltd. (SHE:300529)

Jafron Biomedical Ratios and Metrics

Market cap in millions CNY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 14, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Market Capitalization	17,926	22,720	17,755	24,741	42,653	54,196
Market Cap Growth	13.83%	27.96%	-28.23%	-41.99%	-21.30%	80.19%
Enterprise Value	16,749	21,627	16,803	23,822	41,394	52,930
Last Close Price	23.15	28.29	21.13	28.75	48.52	61.31
PE Ratio	24.97	27.70	40.68	27.81	35.64	61.92
Forward PE	20.00	20.91	20.46	14.20	31.28	53.74
PS Ratio	7.23	8.49	9.24	9.93	15.94	27.78
PB Ratio	5.08	6.81	5.63	6.89	12.61	19.13
P/TBV Ratio	5.23	7.04	5.85	7.20	13.27	20.28
P/FCF Ratio	28.86	27.85	26.52	60.65	59.91	90.27
P/OCF Ratio	22.05	21.62	19.37	27.99	34.14	56.60
EV/Sales Ratio	6.75	8.08	8.74	9.56	15.47	27.13
EV/EBITDA Ratio	16.48	19.32	29.30	23.92	30.15	52.81
EV/EBIT Ratio	18.96	21.67	34.79	25.71	31.27	54.82
EV/FCF Ratio	26.96	26.51	25.10	58.40	58.14	88.16
Debt / Equity Ratio	0.40	0.42	0.53	0.36	0.27	-
Debt / EBITDA Ratio	1.39	1.23	2.90	1.28	0.67	-
Debt / FCF Ratio	2.27	1.70	2.50	3.13	1.29	-
Asset Turnover	0.43	0.49	0.35	0.49	0.67	0.68
Inventory Turnover	1.40	1.44	1.07	1.61	2.54	2.70
Quick Ratio	3.42	3.10	3.49	3.91	7.21	5.44
Current Ratio	3.94	3.63	3.99	4.59	7.91	6.01
Return on Equity (ROE)	21.24%	25.10%	12.63%	25.26%	38.47%	34.89%
Return on Assets (ROA)	9.57%	11.42%	5.51%	11.33%	20.61%	21.13%
Return on Capital (ROIC)	11.07%	13.06%	6.23%	12.63%	23.19%	24.12%
Return on Capital Employed (ROCE)	18.00%	21.60%	10.20%	19.70%	29.90%	33.50%
Earnings Yield	4.04%	3.61%	2.46%	3.60%	2.81%	1.62%
FCF Yield	3.47%	3.59%	3.77%	1.65%	1.67%	1.11%
Dividend Yield	3.35%	2.83%	1.89%	2.33%	1.85%	1.08%
Payout Ratio	46.39%	41.47%	128.71%	82.00%	44.37%	43.17%
Buyback Yield / Dilution	1.94%	1.57%	0.08%	1.12%	0.89%	-2.22%
Total Shareholder Return	5.29%	4.40%	1.97%	3.45%	2.74%	-1.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.